Efeitos Renais Tardios de COVID-19 em Receptores de Transplante Renal: Estudo Unicêntrico
Brazilian Journal of Transplantation,
Journal Year:
2025,
Volume and Issue:
28(1)
Published: Feb. 14, 2025
Introdução:
Durante
a
pandemia
causada
pela
doença
do
coronavírus
2019
(COVID-19),
os
receptores
de
transplante
renal
apresentaram
maiores
taxas
hospitalização
e
mortalidade.
No
entanto,
dados
sobre
efeitos
renais
tardios
da
infecção
são
escassos.
Objetivos:
Este
estudo
tem
como
objetivo
descrever
evolução
função
proteinúria
em
após
infecção.
Métodos:
Estudo
coorte
prospectivo
unicêntrico.
O
total
321
que
sobreviveram
à
COVID-19
março
2020
dezembro
2022
foi
incluído.
Dados
renal,
imunossupressão
foram
analisados
pré-infecção,
3
6
meses
Resultados:
A
maioria
dos
pacientes
era
sexo
masculino
(58,9%),
com
média
idade
50
anos,
receptor
rins
doadores
falecidos
(79,4%)
mediana
tempo
pós-transplante
6,6
anos.
Houve
redução
nível
imunossupressão,
um
escore
Vasudev
pré-infecção
4,66
para
4,50
(p
<
0,001)
no
3º
mês
4,54
=
0,016)
pós-infecção.
taxa
filtração
glomerular
(TFG)
permaneceu
estável,
torno
60
mL/min/1,73
m2.
porcentagem
≥
1,0
aumentou
9,6%
mais
13%
nos
6º
Níveis
elevados
observados
maior
seguimento
pós-transplante,
episódios
rejeição
prévios,
menor
TFG
estimada
prevalência
anticorpos
anti-HLA
doador-específicos.
Conclusão:
Os
tiveram
aumento
na
infecção,
apesar
apresentarem
estável.
Late Renal Effects of COVID-19 in Kidney Transplant Recipients: A Single-Center Study
Brazilian Journal of Transplantation,
Journal Year:
2025,
Volume and Issue:
28(1)
Published: Feb. 14, 2025
Introduction:
During
the
coronavirus
disease
2019
(COVID-19)
pandemic,
kidney
transplant
recipients
had
higher
rates
of
hospitalization
and
mortality.
However,
data
on
late
renal
effects
infection
are
scarce.
Objectives:
This
study
aims
to
describe
evolution
function
proteinuria
in
after
infection.
Methods:
Single-center
prospective
cohort
study.
A
total
321
who
survived
COVID-19
from
March
2020
December
2022
were
included.
Data
function,
proteinuria,
immunosuppression
analyzed
pre-infection,
3
6
months
post-infection.
Results:
Most
patients
male
(58.9%),
with
a
mean
age
50
years,
kidneys
deceased
donors
(79.4%),
median
time
6.6
years.
There
was
reduction
level
immunosuppression,
pre-infection
Vasudev
score
4.66
4.50
(p
<
0.001)
3rd
month
4.54
=
0.016)
The
glomerular
filtration
rate
(GFR)
remained
stable
at
around
60
mL/min/1.73
m2.
percentage
≥
1.0
increased
9.6%
more
than
13%
6th
Higher
levels
observed
longer
follow-up
post-transplant,
previous
rejection
episodes,
lower
estimated
GFR,
prevalence
donor-specific
anti-HLA
antibodies.
Conclusion:
Kidney
an
increase
within
despite
GFR.
Language: Английский
The global burden of chronic kidney disease due to glomerulonephritis: trends and predictions
Xiaotong Wang,
No information about this author
Zhaoyi Liu,
No information about this author
Yi Na
No information about this author
et al.
International Urology and Nephrology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Glomerulonephritis
(GN),
one
of
the
primary
causes
chronic
kidney
disease
(CKD),
is
gaining
recognition
as
a
major
public
health
issue.
This
research
sought
to
evaluate
worldwide
impact
due
glomerulonephritis
(GN-CKD)
between
1990
and
2021
forecast
trends
up
2036,
leveraging
data
from
Global
Burden
Disease
(GBD)
study.
The
analysis
GN-CKD
utilized
GBD
open
secondary
dataset
examine
global
prevalence,
deaths,
disability-adjusted
life
years
(DALYs),
age-standardized
rates
GN-CKD,
changing
these
indicators
were
statistically
analyzed.
To
assess
practical
difference
each
country/region
frontier,
we
DALYs
Socio-Demographic
Index
(SDI).
assist
healthcare
institutions
in
formulating
more
effective
policies,
mortality
rate
until
2036
predicted
using
Bayesian
age-period-cohort
(BAPC)
modeling
techniques.
prevalence
indicated
by
(ASPR),
grew
10.81%
2021,
with
marginal
average
annual
change
0.04
(AAPC0.04,
0.03-0.05).
Similarly,
there
was
an
increase
15.84%
death
(ASDR)
for
during
this
period,
trend
0.50
(AAPC0.50,
0.41-0.59).
Moreover,
(ASYR)
observed
upward
8.60%
modest
0.27
(AAPC0.27,
0.17-0.37).
Our
findings
indicate
that
differs
across
gender,
geographic
areas,
socioeconomic
statuses.
Elevated
fasting
plasma
glucose
levels,
high
body-mass
index
(BMI),
elevated
systolic
blood
pressure
main
contributors
deaths
(DALYs).
Fortunately,
burden
expected
diminish
2036.
has
risen,
variations
genders
SDI
regions.
Encouraging
point
toward
potential
reduction
GN-CKD-related
future.
Language: Английский
Betreuung von Patienten nach Nierentransplantation
Nephrologie aktuell,
Journal Year:
2024,
Volume and Issue:
28(07), P. 333 - 346
Published: Sept. 1, 2024
ZUSAMMENFASSUNG
Zur
Durchführung
einer
Nierentransplantation
(NTx)
ist
die
Zusammenarbeit
im
multiprofessionellen
Team
grundlegend.
Bezogen
auf
Mortalität
und
Lebensqualität
der
Patienten
kann
NTx
als
bestes
Nierenersatzverfahren
angesehen
werden.
Mit
den
Fortschritten
in
immunsuppressiven
Therapie
mittlerweile
ein
sehr
gutes
Transplantatüberleben
ersten
Jahr
(>
95
%)
erreicht
werden,
das
sich
bisher
jedoch
nicht
Langzeitverlauf
übertragen
lässt.
Vor
Aufnahme
Warteliste
für
eine
wird
Transplantationsfähigkeit
durch
multidisziplinäres
Evaluationsprogramm
festgestellt
interdisziplinären
Transplantationskonferenzen
beraten.
Die
Wartezeit
Deutschland
lang
beträgt
8–10
Jahre.
Deshalb
steigt
Anzahl
von
Wartelistenabgängen
aufgrund
Transplantationsunfähigkeit,
häufig
kardiovaskulären
Komplikationen
Adipositas
Gebrechlichkeit
(„frailty“)
herrührt.
Dieser
Artikel
widmet
Strukturen
sowie
dem
Risikomanagement
typischer
Komplikationen,
Komorbiditäten
Risiken
nierentransplantierter
Patienten.
Der
Fokus
liegt
internistischen
urologischen
Problemfeldern
vor
Hintergrund
Komplexität
Immunsuppression
(IS)
nierentransplantierten